To evaluate for potential peripheral conversion of Tregs, in a separate experiment, we instead adoptively transferred CD4+Foxp3–GFP– non-Tregs into LLC-bearing B6CD4–/– recipients, which did not demonstrate any conversion to Tregs in the tumor microenvironment (Supplemental Figure 3D). The gene discussed is FOXP3; the disease is neoplasm.